4.20
Schlusskurs vom Vortag:
$4.05
Offen:
$4.1998
24-Stunden-Volumen:
2,160
Relative Volume:
0.09
Marktkapitalisierung:
$33.86M
Einnahmen:
$31.28M
Nettoeinkommen (Verlust:
$-2.67M
KGV:
-12.67
EPS:
-0.3315
Netto-Cashflow:
$4.94M
1W Leistung:
+5.26%
1M Leistung:
+0.00%
6M Leistung:
+18.31%
1J Leistung:
-9.48%
Cryo Cell International Inc Stock (CCEL) Company Profile
Firmenname
Cryo Cell International Inc
Sektor
Branche
Telefon
813 749 2100
Adresse
700 Brooker Creek Boulevard, Suite 1800, Oldsmar
Compare CCEL vs MOBBW, PSNYW, GOODO, SHMD, CHAD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 5.10 | 0 | 0 | 0 | 0 | 0.00 | |
|
MOBBW
Mobilicom Limited Warrants
|
1.35 | 1.62B | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.35 | 689.98M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
18.80 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.86 | 291.21M | 52.15M | -21.46M | 0 | -0.4675 |
|
CHAD
Direxion Daily CSI 300 China A
|
8.86 | 197.39M | 0 | 0 | 0 | 0.00 |
Cryo Cell International Inc Aktie (CCEL) Neueste Nachrichten
Cryo-Cell Sets Record Date for 2026 Shareholder Meeting - The Globe and Mail
CRYO CELL INTERNATIONAL Announces 2026 Annual Stockholder Meeting Date (AMEX: CCEL) - Kalkine Media
Cryo Cell International sets Oct. 27, 2026 annual meeting; record date Sept. 21, 2026 - TradingView
Cord Blood Industry Consolidation Escalates in 2026 - BioInformant
Stem Cell/Cord Blood Banking Market Research Reveals Path To $24.47 Billion By 2030 - openPR.com
CCEL Q2 2026 Earnings: EPS of $0.07 Beats Zero Estimate, Shares Slip 5.44%Earnings Weakness Phase - dars.gov.et
Stem Cell Umbilical Cord Blood Market Companies, Size & Trends 2026-2035 - Precedence Research
Stem Cell Umbilical Cord Blood Market Size Report, 2033 - Grand View Research
Cryo-Cell (CCEL) Earnings Snapshot: The EPS Result Is Above Expectation for the Current Session; Post-Earnings: The Stock Ends Up 3.56% in Latest TradingFree Cash Flow Trends - vinanet.vn
JEXYY Stock Price and Chart — OTC:JEXYY - TradingView
CCEL Q2 2026 Earnings: EPS of $0.07 Exceeds Expectations, Stock Edges HigherSurprise Factor Analysis - Vinanet
Cell Processing Technologies Market Demonstrates Long-Term Growth Potential At 13.5% CAGR - openPR.com
Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Sahm
CCEL Q2 2026 Earnings: EPS Exceeds Estimates as Shares Rally 14.25%Earnings Season Outlook - vinanet.vn
Cryo-Cell International (CCEL) Slides 2.5% to $3.51 as Key Support at $3.33 LoomsDealer Positioning - dars.gov.et
SARO Stock Price and Chart — NYSE:SARO - TradingView
Cryo-Cell International (CCEL) moves 600,191 shares to new 2026 trust - Stock Titan
Cryo-Cell International Inc (CCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cryo-Cell International (CCEL) Gains 2.25% as Stock Holds Above Key SupportRetail Sentiment - vinanet.vn
Cryo-Cell International (CCEL) Advances 2.3%: Stem Cell Banking Stock Tests Key ResistanceJurik MA - careplusvn.com
Cryo-Cell International, Inc. Revenue Breakdown – AMEX:CCEL - TradingView
Cryo-Cell International Inc (CCEL) Valuation: PE, PB & Fair Value Analysis - TradingKey
CCEL Q2 2026 Earnings: Positive Earnings Surprise as EPS Turns ProfitableDownward Estimate Revision - dars.gov.et
Cryo-Cell International Inc (CCEL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cryo-Cell International Inc (CCEL) Balance Sheet - tradingkey.com
CCEL|Cryo-Cell International Inc|Price:3.460|Chg%:+0.040 - tradingkey.com
CCEL|Cryo-Cell International Inc|Price:3.460| - TradingKey
Cryo-Cell International Inc (CCEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cryo-Cell International, Inc. Revenue Breakdown – FWB:ZCY - TradingView
Cryo-Cell International Inc (CCEL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cryo-Cell International (CCEL) Slips Slightly, Holds Above Key Support at $3.29AAII Bearish - dars.gov.et
Cryo-Cell International Inc (CCEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cryo-Cell International Inc (CCEL) Income Statement - TradingKey
CCEL|Cryo-Cell International Inc|Price:3.600|Chg%:+0.020 - TradingKey
Cryo-Cell International (CCEL) Slips 1.14% as Stock Consolidates Near Key SupportSector ETF Flow - vinanet.vn
CCEL Q2 2026 Earnings: Positive EPS Surprise Amid Quiet Revenue DisclosureLong-Term Guidance - dars.gov.et
Stem Cell Banking Market Size, Growth & Analysis, 2034 - Market Data Forecast
CCEL Q2 2026 Earnings: Positive EPS Surprise Amidst Operational ProgressTrough Earnings Signal - dars.gov.et
Cryo-Cell International (CCEL) Hovers Near Support as Trading Volume Remains SubduedDividend Growth Stocks - dars.gov.et
CCEL Q2 2026 Earnings: EPS Surprises to Positive Territory Despite Stock DeclineDividend Cut Risk - careplusvn.com
Cryo-Cell net income rises 56% to $555,000 in Q2 - scanx.trade
Cryo-Cell International Q2 Revenue USD 7.8 Million - TradingView
CCEL Reports Slight Decrease in Q2 Revenue - GuruFocus
CRYO CELL INTERNATIONAL INC Q2 2026: Revenue $7.78M (Q2), $15.46M (6 months) — 10-Q Summary - TradingView
CCEL: Revenue and net income declined, with expansion paused due to Duke arbitration and NYSE compliance risks - TradingView
[10-Q] CRYO CELL INTERNATIONAL INC Quarterly Earnings Report - Stock Titan
Tranche Update on Cryo-Cell International, Inc.'s Equity Buyback Plan announced on December 12, 2011. - marketscreener.com
Press Release: Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial Results - Moomoo
MSN Money - MSN
OMAB Stock Price and Chart — NASDAQ:OMAB - TradingView
CCEL Q1 2026 Earnings: Surprise Profit Beat Amid Revenue UncertaintyEPS Estimate Trend - dars.gov.et
Finanzdaten der Cryo Cell International Inc-Aktie (CCEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kapitalisierung:
|
Volumen (24h):